Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: A preliminary study

Psychiatria Danubina

Volumn 27, Issue 2, 2015, Pages 180-184

  Çakir, Uʇur ^a   Tuman, Taha Can ^a   Yildirim, Osman ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Inflammation; Lymphocyte; Neutrophil; Neutrophil lymphocyte ratio

Indexed keywords

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; BLOOD CELL COUNT; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; RETROSPECTIVE STUDY; YOUNG MANIA RATING SCALE; BLOOD; LYMPHOCYTE; NEUTROPHIL; PILOT STUDY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE;

ADULT; BIPOLAR DISORDER; BLOOD CELL COUNT; FEMALE; HUMANS; LYMPHOCYTES; MALE; NEUTROPHILS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84937198316     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ayhan SS, Oztürk S, Erdem A, Ozlü MF, Ozyaşar M, Erdem K et al: Relation of neutrophil/lymphocyte ratio with the presence and severity of coronary artery ectasia. Turk Kardiyol Dern Ars 2013; 41:185-90.
2. Altamura AC, Serati M, Albano A, Paoli RA, Glick ID & Dell'Osso B: An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur Arch Psychiatry Clin Neurosci 2011; 261:489-508.
3. Anderson G & Maes M: Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep 2015; 17:541.
4. Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B et al: Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2001; 11:445-52.
5. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience & biobehavioral reviews 2011; 35:804-17.
6. Brietzke E, Kauer-Sant'Anna M, Teixeira AL & Kapczinski F: Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain behavior and immunity 2009; 23:1079-82.
7. Campbell S & MacQueen G: An update on regional brain volume differences associated with mood disorders. Curr opin psychiatr 2006; 19:25-33.
8. Corapcioglu A, Aydemir O & Yildiz M: Turkish version of Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) Printing, Ankara: Hekimler Yayin Birliʇi Publishing, 1999.
9. Dean B: Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies. Int J Neuropsychopharmacol 2011; 14: 997-1012.
10. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA & Klein HC: Neuroinflammation in schizophrenia-related psychosis: a PET study. Journal of Nuclear Medicine 2009; 50:1801-7.
11. Erminio T & Bertoni G: Some physiological and biochemical methods for acute and chronic stress evaluation in dairy cows. Ital J Anim Sci 2009; 8:265-86.
12. Fowler AJ & Agha RA: Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography - the growing versatility of NLR. Atherosclerosis 2013; 228:44-5.
13. Gardner A & Boles RG: Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011; 35:730-43.
14. Grande I, Magalhães PV, Kunz M, Vieta E & Kapczinski F: Mediators of allostasis and systemic toxicity in bipolar disorder. Physiology & behavior 2012; 106:46-50.
15. Harry GJ & Kraft AD: Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology 2012; 33:191-206.
16. Harwood AJ: Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Molecular psychiatry 2004; 10:117-26.
17. Hinze-Selch D: Infection, treatment and immune response in patients with bipolar disorder versus patients with major depression, schizophrenia or healthy controls. Bipolar disorders 2002; 4:81-3.
18. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S et al: Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar disorders 2009; 11:726-34.
19. Huang TL & Lin FC: High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007; 31:370-2.
20. Jilma B, Blann A, Pernerstorfer T, Stohlawetz P, Eichler HG, Vondrovec B et al: Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med. 1999; 159:857-63.
21. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J et al: Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews 2008; 32:675-92.
22. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vázquez GH, Vieta E et al: The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009; 33:1366-71.
23. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt F et al: Peripheral biomarkers and illness activity in bipolar disorder. Journal of psychiatric research 2011; 45:156-61.
24. Karadag F: Reliability and Validity of Turkish Translation of Young Mania Rating Scale. Turk Psikiyatri Derg 2002; 13:107-14.
25. Kim YK, Jung HG, Myint AM, Kim H & Park SH: Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 2007; 104:91-5.
26. Kuyumcu ME, Yesil Y, Oztürk ZA, Kizilarslanoʇlu C, Etgül S, Halil M et al: The evaluation of neutrophillymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 34:69-74.
27. Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R et al: Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 2012; 141:1-10.
28. Leonard BE: The immune system, depression and the action of antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001; 25:767-80.
29. Magalhães PV, Kapczinski F, Nierenberg AA, Deckersbach T, Weisinger D, Dodd S et al: Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand 2012; 125:303-8.
30. Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS et al: The underlying neurobiology of bipolar disorder. World Psychiatry 2003; 2:136.
31. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA et al: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68:241-51.
32. Miller CL, Llenos IC, Dulay JR & Weis S: Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain research 2006; 1073:25-37.
33. Myint AM & Kim YK: Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48:304-13.
34. Na KS, Jung HY & Kim YK: The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48:277-86.
35. Noaghiul S & Hibbeln JR: Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psych 2003; 160:2222-7.
36. Ortiz Domínguez A, Hernández ME, Berlanga C, Gutiérrez Mora D, Moreno J, Heinze G, Pavón L: Immune variations in bipolar disorder: phasic differences. Bipolar disorder 2007; 9:596-602.
37. Post RM & Leverich GS: The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Development and psychopathology 2006; 18:1181-211.
38. Puppe B, Tuchscherer M & Tuchscherer A: The effect of housing conditions and social environment immediately after weaning on the agonistic behaviour, neutrophil/lymphocyte ratio, and plasma glucose level in pigs. Livestock Prod Sci 1997; 48:157-64.
39. Rao JS, Harry GJ, Rapoport SI & Kim HW: Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Molecular psychiatry 2009; 15:384-92.
40. Schneider MR, Del Bello MP, McNamara RK, Strakowski SM, Adler CM et al: Neuroprogression in bipolar disorder. Bipolar disorders 2012; 14:356-74.
41. Semiz M, Yildirim O, Canan F, Demir S, Hasbek E, Tuman TC et al: Elevated Neutrophil/Lymphocyte Ratio in Patients with Schizophrenia. Psychiatr Danub 2014; 26:220-5.
42. Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E & Dimitrakopoulos G: The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg 2013; 205:691-6.
43. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al: Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Molecular psychiatry 2002; 7:579-93.
44. Smith RS: The macrophage theory of depression. Medical Hypotheses 1991; 35:298-306.
45. Smith RS & Maes M: The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Medical Hypotheses 1995; 45:135-41.
46. Steckert AV, Valvassori SS, Moretti M, Dal-Pizzol F & Quevedo J: Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochemical research 2010; 35:1295-301.
47. Stertz L, Magalhaes PV & Kapczinski F: Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 2013; 26:19-26.
48. Szkandera J, Absenger G, Liegl-Atzwanger B, Pichler M, Stotz M, Samonigg H et al: Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer 2013; 108:1677-83.
49. Tremblay M & Majewska AK: A role for microglia in synaptic plasticity? Commun Integr Biol 2011; 4:220-2.
50. Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM et al: The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients. Ren Fail 2012; 34:1229-37.
51. Zahorec R: Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratislavské lekárske listy 2001; 102:5-14.
52. Zarate Jr CA, Singh J & Manji HK: Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biological psychiatry 2006; 59:1006-20.